These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8747795)

  • 21. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance.
    Fujimoto M; Uemura M; Nakatani Y; Tsujita S; Hoppo K; Tamagawa T; Kitano H; Kikukawa M; Ann T; Ishii Y; Kojima H; Sakurai S; Tanaka R; Namisaki T; Noguchi R; Higashino T; Kikuchi E; Nishimura K; Takaya A; Fukui H
    Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):48S-54S. PubMed ID: 10803780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma endothelin-1 levels in patients with disseminated intravascular coagulation.
    Ishibashi M; Saito K; Watanobe K; Uesugi S; Furue H; Yamaji T
    N Engl J Med; 1991 May; 324(21):1516-7. PubMed ID: 2023617
    [No Abstract]   [Full Text] [Related]  

  • 24. Diagnosis and prognosis of overt disseminated intravascular coagulation in a general hospital -- meaning of the ISTH score system, fibrin monomers, and lipoprotein-C-reactive protein complex formation.
    Cauchie P; Cauchie Ch; Boudjeltia KZ; Carlier E; Deschepper N; Govaerts D; Migaud-Fressart M; Woodhams B; Brohée D
    Am J Hematol; 2006 Jun; 81(6):414-9. PubMed ID: 16680742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behaviour of protein C inhibitor in intravascular coagulation and liver disease.
    Francis RB; Thomas W
    Thromb Haemost; 1984 Aug; 52(1):71-4. PubMed ID: 6548588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of tumor necrosis factor in the pathogenesis of intravascular coagulopathy of sepsis: potential new therapeutic implications.
    Aderka D
    Isr J Med Sci; 1991 Jan; 27(1):52-60. PubMed ID: 1995504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A clinical study on the significance of platelet-activating factor in the pathophysiology of septic disseminated intravascular coagulation in surgery.
    Ono S; Mochizuki H; Tamakuma S
    Am J Surg; 1996 Apr; 171(4):409-15. PubMed ID: 8604832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased thrombomodulin mRNA expression on peripheral monocytes in disseminated intravascular coagulation patients relates to poor outcomes: the ex vivo effects of lipopolysaccharide and thrombin on monocyte thrombomodulin and CD14 mRNA.
    Hong SK; Kim JE; Han KS; Kim HK
    Thromb Res; 2013 Sep; 132(3):392-7. PubMed ID: 23954259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Coagulation tests in septic surgical patients].
    Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
    Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Plasma interleukin-6 in patients with disseminated intravascular coagulation].
    Minamikawa K; Wada H; Ohiwa M; Kaneko T; Tsukada T; Kageyama S; Kobayashi T; Tomeoku M; Katou M; Minami N
    Rinsho Ketsueki; 1992 Dec; 33(12):1797-801. PubMed ID: 1479690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional modification of vascular endothelial cells by cytokines during septic shock.
    Endo S; Inada K; Yamada Y; Takakuwa T; Nakae H; Kasai T; Koike S; Inoue Y; Niimi M; Wakabayashi G; Taniguchi S
    Res Commun Mol Pathol Pharmacol; 1996 Oct; 94(1):23-38. PubMed ID: 8948012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dysregulation of inflammatory and hemostatic markers in sepsis and suspected disseminated intravascular coagulation.
    Hoppensteadt D; Tsuruta K; Hirman J; Kaul I; Osawa Y; Fareed J
    Clin Appl Thromb Hemost; 2015 Mar; 21(2):120-7. PubMed ID: 24254894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma concentrations and importance of High Mobility Group Box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation.
    Hatada T; Wada H; Nobori T; Okabayashi K; Maruyama K; Abe Y; Uemoto S; Yamada S; Maruyama I
    Thromb Haemost; 2005 Nov; 94(5):975-9. PubMed ID: 16363239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical usefulness of the measurements of plasmin-alpha 2-plasmin inhibitor complex and plasma tissue factor activity in patients with disseminated intravascular coagulation].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1996 Aug; 44(8):750-6. PubMed ID: 8816061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No interplay between the pathways mediating coagulation and inflammation in tissue factor-induced disseminated intravascular coagulation in rats.
    Ontachi Y; Asakura H; Takahashi Y; Hayashi T; Arahata M; Kadohira Y; Maekawa M; Omote M; Yoshida T; Yamazaki M; Morishita E; Miyamoto K; Nakao S
    Crit Care Med; 2006 Oct; 34(10):2646-50. PubMed ID: 16932226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the responses of global tests of coagulation with molecular markers of neutrophil, endothelial, and hemostatic system perturbation in the baboon model of E. colisepsis--toward a distinction between uncompensated overt DIC and compensated non-overt DIC.
    Wada H; Yamamuro M; Inoue A; Shiku H; Sakuragawa N; Redl H; Peer G; Taylor FB
    Thromb Haemost; 2001 Dec; 86(6):1489-94. PubMed ID: 11776318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia].
    Wang W; Zhang MH; Yu Y; Xu CG
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):681-4. PubMed ID: 18399174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapeutic strategy of newly developing medicines for disseminated intravascular coagulation--activated protein C and thrombomodulin].
    Maruyama I
    Nihon Rinsho; 1993 Jan; 51(1):99-106. PubMed ID: 8381887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin 11 levels in patients with disseminated intravascular coagulation.
    Endo S; Inada K; Arakawa N; Yamada Y; Nakae H; Takakuwa T; Namiki M; Inoue Y; Shimamura T; Suzuki T; Taniguchi S; Yoshida M
    Res Commun Mol Pathol Pharmacol; 1996 Feb; 91(2):253-6. PubMed ID: 8832918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.